Attaya Suvannasankha
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Attaya Suvannasankha
Jun 24, 2024, 07:59 |
Blog
Urvi Shah: Please support our fundraiser for myeloma research while we're trekking through Peru
Urvi Shah, Assistant Attending Physician at Memorial Sloan Kettering Cancer Center, shared a post by Attaya Suvannasankha, …
Jun 23, 2024, 19:16 |
Insight
Joshua Richter: Amazing Paper on Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma
Joshua Richter, Associate Professor of Medicine, Hematology, and Medical Oncology at The Tisch Cancer Institute,…
Jun 21, 2024, 14:36 |
Insight
High ORR and low CRS rate with Linvoseltamab for R/R Multiple Myeloma
Recently Jeffrey Zonder shared a post on X about a recent paper by Naresh Bumma…
Jun 17, 2024, 14:25 |
Insight
Myeloma Paper of the Day, June 17th, suggested by Robert Orlowski
Robert Orlowski shared on X: “Myeloma Paper of the Day: Linvoseltamab BCMA TCE (B-cell maturation antigen,…
May 18, 2024, 03:23 |
Insight
Myeloma Paper of the Day, May 17th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Single cell multi-omic ATAC- and…
All:
5
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube